AIFM2 and metabolic dysfunction-associated steatohepatitis: Immunohistochemistry demonstrated that the protein expression of AIFM2 was markedly increased in liver tissue from NASH patients compared to that in liver tissue from simple steatosis patients (Figure 6E).